Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00012727 · ClinicalTrials.gov registry record · Phase 2
Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 236
- Enrollment target
NCT00012727: Completed Phase 2 study, sponsored by US Department of Veterans Affairs.
NCT00012727 is a Phase 2 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 236 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00012727, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 236 participants
- Enrollment target
Study Summary
This project�s goal is to improve the quality of care and reduce treatment costs for veterans with substance abuse and psychiatric problems.
Interventions
- PROCEDURE Matching Symptom Severity to Service Intensity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 236 participants |
| Est. Completion | 2001-08 |
| Phase | Phase 2 |
What the finished NCT00012727 record still lists
NCT00012727 is an interventional study that assigns participants to a tested intervention. The registered 236 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% higher).
The record links to 0 conditions, and to 1 intervention - of which Matching Symptom Severity to Service Intensity is the first listed.
NCT00012727 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00012727 about?
NCT00012727 is a clinical study titled "Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment". This project�s goal is to improve the quality of care and reduce treatment costs for veterans with substance abuse and psychiatric problems.
What is the current status of trial NCT00012727?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 236 participants. Estimated completion is 2001-08.
What interventions are being tested in trial NCT00012727?
The interventions under investigation include: Matching Symptom Severity to Service Intensity (PROCEDURE).
Who is sponsoring clinical trial NCT00012727?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00012727's enrollment target sits among peer trials
236 255th of 2000 higher than 1,746 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04995341 · 236 participants · NA
Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
- NCT05822362 · 236 participants · Phase 2
CBD for Individuals at Risk for Alzheimer's Disease
- NCT06200103 · 236 participants · Phase 2
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
- NCT06494072 · 236 participants · Phase 4
Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP